HomeACXP • NASDAQ
add
Acurx Pharmaceuticals Inc
Previous close
$1.30
Day range
$1.30 - $1.43
Year range
$1.18 - $5.28
Market cap
21.93M USD
Avg Volume
80.29K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.82M | -9.42% |
Net income | -2.82M | 9.42% |
Net profit margin | — | — |
Earnings per share | -0.17 | 29.17% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.76M | -18.29% |
Total assets | 5.98M | -16.42% |
Total liabilities | 3.32M | 2.96% |
Total equity | 2.66M | — |
Shares outstanding | 16.89M | — |
Price to book | 8.12 | — |
Return on assets | -112.30% | — |
Return on capital | -231.60% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.82M | 9.42% |
Cash from operations | -2.19M | -4.60% |
Cash from investing | — | — |
Cash from financing | 1.59M | — |
Net change in cash | -598.29K | 71.42% |
Free cash flow | -1.60M | -72.72% |
About
CEO
Founded
2017
Website
Employees
4
